Vaccine maker Adimmune Corp (國光生技) yesterday said net profit soared about 162 percent to NT$419 million (US$13.13 million) last quarter from NT$160 million a year earlier, benefiting from rising overseas demands for flu vaccines and contract manufacturing orders.
That was the second straight quarterly net profit made by the vaccine maker after swinging into a net profit of NT$45.3 billion in the second quarter, as it began shipping flu vaccines to local governments, the company said.
During the first three quarters, Adimmune accumulated net profits of NT$230 million, an improvement from losses of NT$251 million made during the same period last year, company data showed.
Earnings per share were NT$0.54 in the first three quarters, compared with losses of NT$0.59 per share a year earlier.
Overall, the company attributed the growth momentum to increases in orders and an improvement in its manufacturing process.
Adimmune earlier this year won a government bid to supply 3.27 million flu vaccines to the Ministry of Health and Welfare for NT$786 million. The third quarter was the peak season for the delivery of flu vaccines, it said.
The company also gained more orders for flu vaccines and flu vaccine ingredients from overseas markets, such as eastern Europe and Thailand. China had previously been the only overseas market, it said.
“Overseas demand is the main engine fueling revenue growth this year. We anticipate seeing our revenue from foreign markets surpass that from domestic market for the first time,” Adimmune said in a statement.
The company has accumulated NT$1.66 billion in revenue during the first three quarters, more than the revenue it made for the whole of last year.
Last year, it made NT$1.64 billion in revenue. Adimmune expects revenue to hit NT$2 billion for the whole of this year, it said.
“It is an achievable target, as we will continue delivering flu vaccines to local governments and begin shipping flu vaccines to China, and gain more revenue from our contract manufacturing business,” it said.
Next year, Adimmune plans to focus on producing flu vaccines in the second and third quarters, while concentrating on contract manufacturing services in the first and fourth quarters, aiming to make stable revenue each quarter, it said.
The domestic unit of the Chinese-owned, Dutch-headquartered chipmaker Nexperia BV will soon be able to produce semiconductors locally within China, according to two company sources. Nexperia is at the center of a global tug-of-war over critical semiconductor technology, with a Dutch court in February ordering a probe into alleged mismanagement at the company. The geopolitical tussle has disrupted supply chains, with some carmakers reportedly forced to cut production due to chip shortages. Local production would allow Nexperia’s domestic arm, Nexperia Semiconductors (China) Ltd (安世半導體中國), to bypass restrictions in place since October on the supply of silicon wafers — etched with tiny components to
Taiwan’s foreign exchange reserves fell below the US$600 billion mark at the end of last month, with the central bank reporting a total of US$596.89 billion — a decline of US$8.6 billion from February — ending a three-month streak of increases. The central bank attributed the drop to a combination of factors such as outflows by foreign institutional investors, currency fluctuations and its own market interventions. “The large-scale outflows disrupted the balance of supply and demand in the foreign exchange market, prompting the central bank to intervene repeatedly by selling US dollars to stabilize the local currency,” Department of Foreign
Taiwan is open to joining a global liquefied natural gas (LNG) program if one is created, but on the condition that countries provide delivery even in a scenario where there is a conflict with China, an energy department official said yesterday. While Taiwan’s priority is to have enough LNG at home, the nation is open to exploring potential strategic reserves in other countries such as Japan or South Korea, Energy Administration Deputy Director-General Chen Chung-hsien (陳崇憲) said. While the LNG market does not have a global reserve for emergencies like that of oil, the concept has been raised a few times —
AI-FUELED DEMAND: The company has been benefiting from the skyrocketing prices for DRAM chips amid the AI frenzy, especially its core product — DDR4 DRAM chips DRAM chipmaker Nanya Technology Corp (南亞科技) yesterday reported that its revenue for the first quarter surged 582.91 percent to NT$49.09 billion (US$1.54 billion) from NT$7.19 billion a year earlier, as the supply crunch caused chip price spikes. Last quarter’s figure is the highest on record. On a quarterly basis, revenue jumped 63.14 percent from NT$30.09 billion, the company said. In January, Nanya Technology expected global DRAM supply scarcity to continue through the first half of 2028, thanks to strong demand for artificial intelligence (AI) applications. Market researcher TrendForce Corp (集邦科技) forecast prices of standard DRAM chips would rise between 58 percent and 63
RSS